Seelos Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Seelos Therapeutics, Inc. (SEEL) is 11.45M

According to Seelos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.45M. This represents a change of -98.85% compared to the average of 992.21M of the last 4 quarters.

Seelos Therapeutics, Inc. (SEEL) Historical Enterprise Value (quarterly & annually)

How has SEEL Enterprise Value performed in the past?

The mean historical Enterprise Value of Seelos Therapeutics, Inc. over the last ten years is 46.11B. The current 11.45M Enterprise Value has changed -97.52% with respect to the historical average. Over the past ten years (40 quarters), SEEL's Enterprise Value was at its highest in in the March 2015 quarter at 342.05B. The Enterprise Value was at its lowest in in the June 2024 quarter at 18.42M.

Seelos Therapeutics, Inc. (SEEL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Seelos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seelos Therapeutics, Inc. (SEEL) Average Enterprise Value

How has SEEL Enterprise Value performed in the past?

The current Enterprise Value of Seelos Therapeutics, Inc. (SEEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Seelos Therapeutics, Inc. (SEEL) Enterprise Value vs. Peers

How is SEEL’s Enterprise Value compared to its peers?

Seelos Therapeutics, Inc.’s Enterprise Value is greater than Virios Therapeutics, Inc. (-12876407.00), greater than TC Biopharm (Holdings) Plc (-466971.60), greater than Bellerophon Therapeutics, Inc. (-6574209.00), greater than TFF Pharmaceuticals, Inc. (-5074061.00), less than LakeShore Biopharma Co., Ltd (405.01M), less than Akerna Corp. (192.56M), greater than Histogen Inc. (-7392565.00), less than ProSomnus, Inc. (42.48M), less than Immatics N.V. (856.34M),

Build a custom stock screener for Seelos Therapeutics, Inc. (SEEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seelos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seelos Therapeutics, Inc. (SEEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seelos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.